Pulse Brain · Growing Health Evidence Index
Tier 3 — Observational / field trialPreprint

Lactoferrin and lysozyme for Kenyan children presenting with wasting and diarrhea: A 2 x 2 factorial randomized controlled trial

Tickell, K. D.; Tiwari, R.; Trehan, I.; Otieno, J.; Okello, M.; Shah, A.; Keter, L.; Yoshioka, E.; Ochola, E.; Nyabinda, C.; Rwigi, D.; Njunge, J. M.; Houpt, E.; Platts-Mills, J. A.; Liu, J.; Richardson, B. A.; McGrath, C. J.; Means, A. R.; Diakhate, M. M.; Stewart, G. J.; Walson, J. L.; Singa, B. O.; Pavlinac, P. B.

medRxiv · 2026

Read source ↗ All evidence

Summary

Introduction: Lactoferrin and lysozyme are milk derived proteins with antimicrobial and anti-inflammatory properties. We tested if these supplements improved time-to-nutritional-recovery and reduced the incidence of new moderate or severe diarrhea (MSD) among children presenting to hospital with wasting and diarrhea. Methods: Medically-stable children aged 6-24 months with diarrhea and wasting were randomized to a 16-week course of lactoferrin, lysozyme, a combination of both, or placebo. Time-to-nutritional-recovery (mid-upper arm circumference [≥] 12.5cm) and incidence of new onset MSD were the primary outcomes observed over 6-months follow-up. Subgroup analyses included efficacy by wasting status (severe vs. moderate), stunting, age, inpatient/outpatient, and adherence. Results: Among the 600 children randomized, 531 (88.5%) nutritionally recovered within 16-weeks; 63% among severely wasted children and 95% in children with moderate wasting. The wasting recovery rate in the combination arm was non significantly higher (HR: 1.23, 95%CI: 0.97, 1.57; p=0.083) than the placebo group. Children randomized to lactoferrin alone and lysozyme alone had nutritional recovery rates similar to placebo (HR: 0.94, 95% CI 0.74, 1.20; p=0.607 and HR: 0.91, 95% CI: 0.71, 1.17; p=0.462, respectively). Among severely wasted children, the combination arm had a higher recovery rate than placebo (HR: 2.76, 95% CI 1.49, 5.09; p=0.001), but not the individual lactoferrin (HR: 1.29, 95% CI 0.69, 2.41; p=0.427) and lysozyme (HR: 0.80, 95% CI: 0.40, 1.60; p=0.530) arms. Children randomized to intervention arms had comparable incidence of MSD (82.3-97.0 per 100 child-years) to the placebo arm (75.3 per 100 child-years). Conclusions: The combination of lactoferrin and lysozyme for 16 weeks modestly improved nutritional recovery time particularly among severely wasted children. If confirmed, there may be a role for enteric-targeted therapeutics as adjuvants to severe wasting management. Additional strategies are needed for the post-acute diarrhea recovery period.

Outcomes reported

Introduction: Lactoferrin and lysozyme are milk derived proteins with antimicrobial and anti-inflammatory properties. We tested if these supplements improved time-to-nutritional-recovery and reduced the incidence of new moderate or severe diarrhea (MSD) among children presenting to hospital with wasting and diarrhea. Methods: Medically-stable children aged 6-24 months with diarrhea and wasting were randomized to a 16-week course of lactoferrin, lysozyme, a combination of both, or placebo. Time-to-nutritional-recovery (mid-upper arm circumference [≥] 12.5cm) and incidence of new onset MSD were the primary outcomes observed over 6-months follow-up. Subgroup analyses included efficacy by wasting status (severe vs. moderate), stunting, age, inpatient/outpatient, and adherence. Results: Among the 600 children randomized, 531 (88.5%) nutritionally recovered within 16-weeks; 63% among severely wasted children and 95% in children with moderate wasting. The wasting recovery rate in the combination arm was non significantly higher (HR: 1.23, 95%CI: 0.97, 1.57; p=0.083) than the placebo group. Children randomized to lactoferrin alone and lysozyme alone had nutritional recovery rates similar to placebo (HR: 0.94, 95% CI 0.74, 1.20; p=0.607 and HR: 0.91, 95% CI: 0.71, 1.17; p=0.462, respectively). Among severely wasted children, the combination arm had a higher recovery rate than placebo (HR: 2.76, 95% CI 1.49, 5.09; p=0.001), but not the individual lactoferrin (HR: 1.29, 95% CI 0.69, 2.41; p=0.427) and lysozyme (HR: 0.80, 95% CI: 0.40, 1.60; p=0.530) arms. Children randomized to intervention arms had comparable incidence of MSD (82.3-97.0 per 100 child-years) to the placebo arm (75.3 per 100 child-years). Conclusions: The combination of lactoferrin and lysozyme for 16 weeks modestly improved nutritional recovery time particularly among severely wasted children. If confirmed, there may be a role for enteric-targeted therapeutics as adjuvants to severe wasting management. Additional strategies are needed for the post-acute diarrhea recovery period.

Theme
Farming systems, soils & land use
Subject
Arable cropping systems
Study type
Research
Source type
Preprint
Status
Preprint
Geography
United Kingdom
System type
Other
DOI
10.64898/2026.04.27.26351844
Catalogue ID
IRmoq8418w-e44c8b
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.